Clinical Research Associates is coordinating a clinical study for a protein-based COVID-19 vaccine, or what is commonly known as a traditional COVID-19 vaccine, and we are seeking help from our community to help study the investigational medicine. Below are details about the study, and information about how to help. COVID-19 is an infectious disease that […]
The FDA announced today, February 11, 2022, that it would wait for data on whether three doses of Pfizer’s coronavirus vaccine are effective in children younger than five before deciding to authorize a vaccine for the age group. The FDA will no longer meet next week to weigh the evidence and make a recommendation on
FDA Delays Action on COVID Shots for Young Children Read More »
On Friday, Pfizer announced that it will expand ongoing clinical trials of its COVID-19 vaccine in children to include a third dose for patients as young as 6 months old. Clinical Research Associates, Inc. will be part of this study expansion. However, at this time we do not have instructions to begin this work. As
Third Dose for Pediatric Patients Read More »
Nashville’s daily newspaper, The Tennessean, recently highlighted Clinical Research Associates’ role in a recent article, headlined “This week in COVID-19: Pfizer vaccine for kids, mandates for workers.” In the article, healthcare reporter Brett Kelman spoke with Allison King, whose three sons are enrolled in the pediatric COVID-19 vaccine clinical study here at Clinical Research Associates.
Local Media Highlights CRA’s Role in Pediatric Vaccine Clinical Study Read More »
Important Update for Pediatric COVID-19 Vaccine Patients & Caregivers As you may know, the United States Food and Drug Administration (FDA) recently authorized Pfizer’s COVID-19 vaccine for use in individuals aged 5-11 years old. This tremendous scientific achievement is due to families like yours, who stepped up to join the clinical study for this life-saving
Important Update for Pediatric COVID-19 Vaccine Patients & Caregivers Read More »
Original story ran on WSMV Nashville News 4 here Teen Encouraging Others to Join Vaccine Trial NASHVILLE, TN (WSMV) – A local 16-year-old encourages others to participate in a COVID-19 teen vaccine trial. The Novavax Vaccine will hold a trial that aims to see how effective it is in children ages 12 to 17. Lipscomb
Teen Encouraging Others to Join Vaccine Trial Read More »
Mayor Cooper, Clinical Research Associates, Meharry Medical College, Vanderbilt University Thank COVID-19 Vaccine Clinical Trial Volunteers Volunteers have once again come to the aid of Nashvillians. Last fall and winter, more than 1,400 selfless neighbors, friends and family members enrolled in clinical trials for COVID-19 vaccines through Clinical Research Associates, Meharry Medical College and Vanderbilt
